The HDAC inhibitor Trichostatin A (TSA), which specifically inhibits class I and II mammalian HDAC families, has been shown to increase p73 expression and promote Bax-dependent apoptosis in cisplatin resistant ovarian cancer cells (121). Here, HDAC9 is linked to ovarian carcinoma.